Transforming growth factor-β and the progression of renal disease

245Citations
Citations of this article
125Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Transforming growth factor-β (TGF-β) is a profibrotic cytokine found in chronic renal diseases, which initiates and modulates a variety of pathophysiological processes. It is synthesized by many renal cell types and exerts its biological functions through a variety of signalling pathways, including the Smad and MAPK pathways. In renal diseases, TGF-β is upregulated and induces renal cells to produce extracellular matrix proteins leading to glomerulosclerosis as well as tubulointerstitial fibrosis. Different types of renal cells undergo different pathophysiological changes induced by TGF-β, leading to apoptosis, hypertrophy and abnormalities of podocyte foot processes, which ultimately result in renal dysfunction. In this review, we describe the effects of TGF-β on different renal cell types and the means by which TGF-β participates in the pathomechanisms of glomerular and tubulointerstitial diseases. © The Author 2013.

Cite

CITATION STYLE

APA

Loeffler, I., & Wolf, G. (2014). Transforming growth factor-β and the progression of renal disease. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gft267

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free